accounthow much compensation would be disbursed, said the de facto monopoly enjoyed by some brands led to inflated drug prices. As an example, the president of Ecuador's Intellectual Property Institute (IEPI), Andres Ycaza, cited the case of a local laboratory...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Firms accept Ecuador plan to break pharma patents
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account